The Association between Thyroid-Stimulating Hormone and Long-Term Outcomes in Patients with ST Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
Yuansong ZhuJian ShenYuzhou XueZhenxian XiangYi JiangWei ZhouSuxin LuoPublished in: International journal of general medicine (2021)
Only TSH elevation beyond the normal range was associated with worse long-term prognosis in STEMI patients, while high-normal TSH or reduced TSH did not alter long-term prognosis of STEMI patients. TSH >3.5 mIU/L was an independent risk factor for long-term mortality in STEMI.
Keyphrases
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- end stage renal disease
- st elevation myocardial infarction
- acute coronary syndrome
- newly diagnosed
- ejection fraction
- acute myocardial infarction
- antiplatelet therapy
- chronic kidney disease
- coronary artery disease
- coronary artery bypass grafting
- peritoneal dialysis
- prognostic factors
- heart failure
- type diabetes